Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 4, 2010, Pages

  Duley, Lelia ^a   Matar, Hosam E ^b   Almerie, Muhammad Qutayba ^c   Hall, David R ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

^c National Collaborating Centre for Women's and Children's Health   (United Kingdom)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM SULFATE;

ECLAMPSIA; FEMALE; HUMAN; META ANALYSIS; PREECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77955963595     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007388.pub2     Document Type: Review

References (61)

1. Begum A. Loading dose vs standard regime of magnesium sulphate in the management of eclampsia - a randomized trial [abstract]. XVI FIGO World Congress of Obstetrics & Gynecology (Book 2); 2000 Sept 3-8; Washington DC, USA. 2000:47.
2. Begum MR, Begum A, Quadir E. Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial. Journal of Obstetrics and Gynaecology Research 2002;28:154-9.
3. Shilva, Saha SC, Kalra J, Prasad R. Safety and efficacy of low-dose MgS04 in the treatment of eclampsia. International Journal of Gynecology & Obstetrics 2007;97(2):150-1.
4. Suneja A, Sinha S, Vaid N, Ahuja S. A prospective randomized controlled trial to individualize the duration of post partum magnesium sulfate therapy. Hypertension in Pregnancy 2008;27(4):504.
5. Chissell S, Botha JH, Moodley J, McFadyen L. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. South African Medical Journal 1994;84:607-10.
6. Fontenot MT, Lewis DF, Frederick JB, Wang Y, DeFranco EA, Groome LJ, et al. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy. American Journal of Obstetrics and Gynecology 2005;192:1788-94.
7. Wang Y, Zhang Y, Canzoneri BJ, Gu Y, Philibert L, Lewis DF. Prostacyclin and thromboxane levels in women with severe preeclampsia undergoing magnesium sulfate therapy during antepartum and postpartum periods. Hypertension in Pregnancy 2008;27(1):17-27.
8. Ehrenberg H, Mercer B. Abbreviated post-partum magnesium sulfate therapy for women with mild preeclampsia [abstract]. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S73.
9. Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstetrics & Gynecology 2006;108(4):833-8.
10. Begum K. A lower dose of magnesium sulphate for control of convulsion in eclamptic women of Bangladesh. International Journal of Gynecology & Obstetrics 2009; Vol. 107, issue Suppl 2:S124.
11. Abbade JF, Costa RA, Martins AM, Borges VT, Rudge MV, Peraçoli JC. Zuspan's scheme versus an alternative magnesium sulfate scheme: Randomized clinical trial of magnesium serum concentrations. Hypertension in Pregnancy 2010;29(1):82–92.
12. Abbade JF, Costa RAA, Martins AMVC, Rudge MVC, Peracoli JC. Zuspan's scheme versus alternative scheme of magnesium sulphate to prevent or to treat eclampsia: comparison of magnesium serum concentrations [abstract]. Hypertension in Pregnancy 2006;25(Suppl 1):152.
13. Chowdhury JR, Chaudhuri S, Bhattacharyya N, Biswas PK, Panpalia M. Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia. Journal of Obstetrics and Gynaecology Research 2009;35(1):119-25.
14. Mundle S, Regi A, Biswas B, Bracken H, Easterling T, Winikoff B. Preeclampsia in low-resource settings: a randomized trial of IV MgSO4 via flow controlled pump. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S278.
15. Ghahiri A, Berjis K. A comparison between intravenous magnesium sulfate and oral magnesium chloride in mild preeclampsia. Journal of Research in Medical Sciences 2005;10(1):6-9.
16. Muhammad A, Ibrahim U, Nighat K, Muhammad Y, Abdullahi A. Low dose magnesium sulfate in the control of eclamptic fits: a randomized control trial. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S277-8.
17. Tongsong T, Dejkijwikrom W, Tansuwannont W, Jantachai U, Siangpura U. A comparison of intravenous magnesium sulfate regimens in preeclampsia-eclampsia between rate 1 gram and 2 grams per hour. Siriraj Hospital Gazette 1992;44(7):509-16.
18. Manorot M, Tongsong T, Khettglang T. A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: a randomized controlled trial. Journal of the Medical Association of Thailand 1996;79(2):76-82.
19. Laiteerapong U, Leelahakorn S. Comparative study of serum magnesium levels attained from magnesium sulfate therapy for severe pre-eclamptic patients between 1 gm/hr and 2 gm/hr regimen. Thai Journal of Obstetrics and Gynaecology 1999;11(4):281.
20. Stallworth JC, Yeh SY, Petrie RH. The effect of magnesium sulfate on fetal heart rate variability and uterine activity. American Journal of Obstetrics and Gynecology 1981;140:702-6.
21. Gloeb DJ, O'Sullivan MJ. Comparison of effects of intramuscular and intravenous magnesium sulfate regimens in pre-eclamptic patients on intrapartum events and maternal/neonatal outcome. Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 Feb 1-4; New Orleans, Louisiana, USA. 1989:494.
22. Belfort MA, Moise KJJ. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo controlled study. American Journal of Obstetrics and Gynecology 1992;167:661-6.
23. Bhalla AK, Dhall GI, Dhall K. A safer and more effective treatment regimen for eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology 1994;34:144-8.
24. Chesley L. Survey of management and case mortality. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts, 1978:309-40.
25. Anonymous. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63.
26. Crowther C. Eclampsia at Harare Maternity Hospital. An epidemiological study. South African Medical Journal 1985;68:927-9.
27. Dinsdale HB. Does magnesium sulfate treat eclamptic seizures? Yes. Archives of Neurology 1988;45:1360-1.
28. Donaldson JO. The case against magnesium sulfate for eclamptic convulsions. International Journal of Obstetric Anesthesia 1992;1:159-66.
29. Dorsett L. The intramuscular injection of magnesium sulfate for the control of convulsions in eclampsia. American Journal of Obstetrics and Gynecology 1926;11:227-31.
30. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994;309:1395-400.
31. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004661.pub3]
32. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. British Journal of Obstetrics and Gynaecology 1992;99:547-53.
33. Duley L, Johanson R. Magnesium sulphate for pre-eclampsia and eclampsia: the evidence so far. British Journal of Obstetrics and Gynaecology 1994;101:565-7.
34. Duley L, Henderson-Smart DJ. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews 1995, Issue 4. [DOI: 10.1002/14651858.CD000128]
35. Duley L. Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial. British Journal of Obstetrics and Gynaecology 1996;103:103-5.
36. Duley L, Gulmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews 2000, Issue 3. [Art. No.: CD002960. DOI: 10.1002/14651858.CD002960]
37. Duley L, Henderson-Smart DJ. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD000127]
38. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2003, Issue 2. [Art. No.: CD000025. DOI: 10.1002/14651858.CD000025]
39. Eastman NJ, Steptoe PP. The management of pre-eclampsia. Canadian Medical Association Journal 1945;52:562-8.
40. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
41. Goldman R, Finkbeiner SM. Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. New England Journal of Medicine 1988;319:1224-5.
42. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443-57.
43. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
44. Kaplan PW, Lesser RP, Fisher RS, Repke JT, Hanley DF. No, magnesium sulfate should not be used in treating eclamptic seizures. Archives of Neurology 1988;45:1361-4.
45. Khan K, Wojdyla D, Say L, Gülmezoglu A, Van Look P. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
46. Knight M, on behalf of UKOSS. Eclampsia in the United Kingdom 2005. BJOG: an international journal of obstetrics and gynaecology 2007;114(9):1072-8.
47. Lazard EM. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. American Journal of Obstetrics and Gynecology 1925;9:178-88.
48. Lean TH, Ratnam SS, Sivasamboo R. The use of chlordiazepoxide in patients with severe pregnancy toxaemia. (A preliminary study of effects on the newborn infants). Journal of Obstetrics and Gynaecology of the British Commonwealth 1968;75:853-5.
49. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
50. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. American Journal of Obstetrics and Gynecology 2004;90:1464-6.
51. Meher S, Duley L, Prevention of Pre-eclampsia Cochrane Review authors. Interventions for preventing pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2005, Issue 2. [Art. No.: CD005301. DOI: 10.1002/14651858.CD005301]
52. Pritchard JA. The use of magnesium ion in the management of eclamptogenic toxemias. Surgery, Gynecology and Obstetrics 1955;100:131-40.
53. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
54. Sadeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke 1989;20:1273-5.
55. Sibai BM, Spinnato JA, Watson DL, Lewis JA, Anderson GD. Effect of magnesium sulfate on electroencephalographic findings in preeclampsia-eclampsia. Obstetrics & Gynecology 1984;64:261-6.
56. Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. American Journal of Obstetrics and Gynecology 1990;162:1141-5.
57. Simon J, Gray A, Duley L on behalf of the Magpie Trial Collaborative Group. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial. BJOG: an international journal of obstetrics and gynaecology 2006;113:144–51.
58. Slater RM, Smith WD, Patrick J, Mawer G. Phenytoin infusion in severe pre-eclampsia. Lancet 1987;i:1417-21.
59. Stroganoff W, Davidovitch O. Two hundred cases of eclampsia treated with magnesium sulphate. A preliminary report. Journal of Obstetrics and Gynaecology 1937;44:289-99.
60. World Health Organization International Collaborative Study. Geographic variation in the incidence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 1988;158:80-3.
61. Zuspan FP. Problems encountered in the treatment of pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 1978;131:591-7.